BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zanchetti A, Omboni S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol. 2001;38:642-650. [PMID: 11588535 DOI: 10.1097/00005344-200110000-00017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 McKeage K, Scott LJ. Manidipine: a review of its use in the management of hypertension. Drugs. 2004;64:1923-1940. [PMID: 15329044 DOI: 10.2165/00003495-200464170-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
2 Mugellini A, Vaccarella A, Celentano A, Scanferla F, Zoppi A, Fogari R. Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Blood Press Suppl 2005;1:6-13. [PMID: 16060411 DOI: 10.1080/08038020510040621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 de la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens 2009;23:503-11. [PMID: 19148104 DOI: 10.1038/jhh.2008.157] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
4 Fogari R, Mugellini A, Circelli M, Cremonesi G. Combination delapril/manidipine as antihypertensive therapy in high-risk patients. Clin Drug Investig 2011;31:439-53. [PMID: 21627336 DOI: 10.2165/11589000-000000000-00000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Cheer SM, McClellan K. Manidipine: a review of its use in hypertension. Drugs 2001;61:1777-99. [PMID: 11693466 DOI: 10.2165/00003495-200161120-00010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
6 Martinez-Martin FJ, Saiz-Satjes M. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. Expert Rev Cardiovasc Ther. 2008;6:1347-1355. [PMID: 19018688 DOI: 10.1586/14779072.6.10.1347] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
7 Messerli FH. Vasodilatory edema: A common side effect of antihypertensive therapy. Curr Cardiol Rep 2002;4:479-82. [DOI: 10.1007/s11886-002-0110-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
8 Payeras AC, Sladek K, Lembo G, Alberici M. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study. Clin Drug Investig 2007;27:623-32. [PMID: 17705571 DOI: 10.2165/00044011-200727090-00004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Makani H, Bangalore S, Romero J, Htyte N, Berrios RS, Makwana H, Messerli FH. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate--a meta-analysis of randomized trials. J Hypertens 2011;29:1270-80. [PMID: 21558959 DOI: 10.1097/HJH.0b013e3283472643] [Cited by in Crossref: 50] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
10 Bramlage P, Wolf WP, Fronk EM, Stuhr T, Erdlenbruch W, Wasem J, Ketelhut R, Schmieder RE. Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care. Expert Opin Pharmacother 2010;11:2779-90. [PMID: 20929435 DOI: 10.1517/14656566.2010.521499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kushiro T, Watanabe N, Takahashi A, Koike M, Saito F, Otsuka Y, Kanmatsuse K. Different effects of L-type and L+N-type calcium channel blockers on hamster cheek pouch venules. J Cardiovasc Pharmacol 2004;44:672-5. [PMID: 15550786 DOI: 10.1097/00005344-200412000-00008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Baguet JP, Robitail S, Boyer L, Debensason D, Auquier P. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am J Cardiovasc Drugs 2005;5:131-40. [PMID: 15725044 DOI: 10.2165/00129784-200505020-00007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
13 Martell-Claros N, de la Cruz JJ. Manidipine for hypertension not controlled by dual therapy in patients with diabetes mellitus: a non-comparative, open-label study. Clin Drug Investig 2011;31:427-34. [PMID: 21528940 DOI: 10.2165/11587400-000000000-00000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Rizos CV. Manidipine: A different dihydropyridine. WJH 2011;1:3. [DOI: 10.5494/wjh.v1.i1.3] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
15 Baguet JP, Legallicier B, Auquier P, Robitail S. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clin Drug Investig 2007;27:735-53. [PMID: 17914893 DOI: 10.2165/00044011-200727110-00001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
16 Ahmed AI, van der Heijden FM, van den Berkmortel H, Kramers K. A man who wanted to commit suicide by hanging himself: an adverse effect of ciprofloxacin. Gen Hosp Psychiatry 2011;33:82.e5-7. [PMID: 21353135 DOI: 10.1016/j.genhosppsych.2010.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Richy FF, Laurent S. Efficacy and safety profiles of manidipine compared with amlodipine: a meta-analysis of head-to-head trials. Blood Press. 2010;20:54-59. [PMID: 20945994 DOI: 10.3109/08037051.2010.518670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Ott C, Schneider MP, Raff U, Ritt M, Striepe K, Alberici M, Schmieder RE. Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension. Br J Clin Pharmacol. 2013;75:129-135. [PMID: 23240643 DOI: 10.1111/j.1365-2125.2012.04336.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
19 Sica DA. Calcium Channel Blocker‐Related Peripheral Edema: Can It Be Resolved? The Journal of Clinical Hypertension 2007;5:291-5. [DOI: 10.1111/j.1524-6175.2003.02402.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
20 Malacco E, Varì N, Capuano V, Spagnuolo V, Borgnino C, Palatini P; Val-Syst study. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. Clin Ther 2003;25:2765-80. [PMID: 14693303 DOI: 10.1016/s0149-2918(03)80332-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
21 Pedrinelli R, Dell'Omo G, Nuti M, Menegato A, Balbarini A, Mariani M. Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens 2003;21:1969-73. [PMID: 14508205 DOI: 10.1097/00004872-200310000-00026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
22 Otero ML, Claros NM. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: A multicenter, randomized, double-blind, 24-week study. Clinical Therapeutics 2005;27:166-73. [DOI: 10.1016/j.clinthera.2005.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
23 Roca-Cusachs A, Triposkiadis F. Antihypertensive effect of manidipine. Drugs 2005;65 Suppl 2:11-9. [PMID: 16398058 DOI: 10.2165/00003495-200565002-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
24 Coca A. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage. Expert Review of Cardiovascular Therapy 2014;5:147-59. [DOI: 10.1586/14779072.5.2.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Sica DA, Prisant LM. Pharmacologic and Therapeutic Considerations in Hypertension Therapy With Calcium Channel Blockers: Focus on Verapamil. J Clin Hypertension 2007;9:1-22. [DOI: 10.1111/j.1524-6175.2007.06504.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
26 Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers. Expert Rev Cardiovasc Ther 2010;8:751-7. [PMID: 20528630 DOI: 10.1586/erc.10.48] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Zanchetti A. Calcium Channel Blockers in Hypertension. Hypertension: A Companion to Braunwald’s Heart Disease. Elsevier; 2013. pp. 204-18. [DOI: 10.1016/b978-1-4377-2766-1.00022-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]